+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Kyverna Therapeutics

KYTXNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$9.75

0.040.41%

Pre-Market: 8:01 AM EDT

15 minutes delayed

Kyverna Therapeutics (KYTX) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Kyverna Therapeutics (NASDAQ:KYTX) Stock

Kyverna Therapeutics Stock (NASDAQ: KYTX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, July 19, 2024

Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges
Vandana Singh

Tuesday, July 16, 2024

HC Wainwright & Co. Reiterates Neutral on Kyv...
Benzinga Newsdesk
Bank Of America, Morgan Stanley And Other 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor

Monday, July 15, 2024

Kyverna Therapeutics shares are trading highe...
Benzinga Newsdesk
Kyverna's KYV-101 Receives U.S. FDA Regenerat...
Benzinga Newsdesk

Wednesday, July 03, 2024

HC Wainwright & Co. Initiates Coverage On Kyv...
Benzinga Newsdesk

Thursday, June 20, 2024

Kyverna Therapeutics shares are trading highe...
Benzinga Newsdesk
FDA Authorizes Clearance For Kyverna's KYV-10...
Benzinga Newsdesk

Monday, June 17, 2024

Kyverna Therapeutics Presents First-In-Diseas...
Benzinga Newsdesk

Friday, June 14, 2024

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Kyverna Therapeutics Stock Is Sinking
Erica Kollmann
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Kyverna Therapeutics shares are trading lower...
Benzinga Newsdesk
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
Avi Kapoor

Thursday, June 13, 2024

Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
Avi Kapoor

Friday, June 07, 2024

Kyverna Therapeutics To Present Data From Coh...
Benzinga Newsdesk

Monday, June 03, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Tuesday, May 14, 2024

Kyverna Therapeutics Q1 2024 Adj EPS $(1.12) ...
Benzinga Newsdesk

Monday, April 29, 2024

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor

Thursday, April 11, 2024

Kyverna Therapeutics To Attend The 2024 AAN A...
Benzinga Newsdesk

Monday, April 01, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Tuesday, March 26, 2024

Kyverna Therapeutics FY23 EPS $(89.61) Vs $(6...
Benzinga Newsdesk

Friday, March 08, 2024

Kyverna Therapeutics And Stanford University ...
Benzinga Newsdesk

Monday, March 04, 2024

JP Morgan Initiates Coverage On Kyverna Thera...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Kyverna ...
Benzinga Newsdesk

Thursday, February 08, 2024

Kyverna Therapeutics IPO Shares Open For Trad...
Benzinga Newsdesk
IPO For Kyverna Therapeutics Is Open For Quot...
Benzinga Newsdesk
Trading Halt: Halt status updated at 10:10:00...
Benzinga Newsdesk
Kyverna Therapeutics Prices Upsized Initial P...
Benzinga Newsdesk

Wednesday, February 07, 2024

Kyverna Therapeutics, Inc To Start Trading Tomorrow
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved